Associated Papers
Distinct genomic subgroups and mutational patterns in undifferentiated/dedifferentiated endometrial carcinoma.
Huang CY et al.
Bmc Cancer, 2025
41068688 (PubMed )
Supplement: 12885_2025_15053_MOESM2_ESM.xlsx › Table.S4
From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models.
Capasso M et al.
Journal of Translational Medicine, 2024
38351008 (PubMed )
Supplement: 12967_2024_4954_MOESM2_ESM.xlsx › Table_S4
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer.
Wong K et al.
Genome Biology, 2023
37635261 (PubMed )
Supplement: 13059_2023_3026_MOESM3_ESM.xlsx › Table_S2
Detection of oncogenic and clinically actionable mutations in cancer genomes critically depends on variant calling tools.
Garcia-Prieto CA et al.
Bioinformatics (oxford, England), 2022
35512388 (PubMed )
Supplement: btac306_supplementary_data.zip › Supplementary_files.zip › Supplementary_files › Supplementary_file_10.xlsx › Sheet1
Intratumor genetic heterogeneity and clonal evolution to decode endometrial cancer progression.
Mota A et al.
Oncogene, 2022
35145232 (PubMed )
Supplement: 41388_2022_2221_MOESM3_ESM.xlsx › EEC-5
Diverse immune response of DNA damage repair-deficient tumors.
Qing T et al.
Cell Reports. Medicine, 2021
Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy.
Li Z et al.
Science Advances, 2020
32133402 (PubMed )
Supplement: aay4211_Table_S2.xlsx › SomaticMutations
HLA class I restricted epitopes prediction of common tumor antigens in white and East Asian populations: Implication on antigen selection for cancer vaccine design.
Hu W et al.
Plos One, 2020
32106223 (PubMed )
Supplement: pone.0229327.s001.xlsx › mutation_abbreviation
Select a paper to view details